Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL
Clinical trial NCT05918276 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05918276
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-15
- Primary completion
- 2024-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.